mTORC1 and mTORC2 Co-Protect against Cadmium-Induced Renal Tubular Epithelial Cell Apoptosis and Acute Kidney Injury

Jiaqiao Zhu1,2,3, Zhonggui Gong1,4,5, Xueru Wang1,2,3

  • 1College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, China.

Insights

Cadmium exposure causes kidney injury. This study shows that mTORC1 and mTORC2 complexes protect kidney cells from apoptosis by regulating AKT activity and autophagy, offering therapeutic targets for renal disease.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cellular Biology

Background:

  • Cadmium (Cd) exposure poses a growing threat, leading to acute kidney injury (AKI).
  • Understanding the molecular mechanisms underlying Cd-induced kidney cell apoptosis is crucial for developing effective treatments.
  • The mechanistic target of rapamycin (mTOR) pathway is implicated in cellular stress responses and survival.

Purpose of the Study:

  • To investigate the distinct roles of mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) in cadmium-induced apoptosis in mouse kidney cells.
  • To elucidate the involvement of protein kinase B (AKT) activation and autophagy in these processes.
  • To explore the therapeutic potential of modulating mTOR activity in cadmium nephrotoxicity.

Main Methods:

  • Construction of a mouse model with specific deletion of Raptor/Rictor in renal cells.
  • Application of specific inhibitors and activators for mTORC1 and mTORC2.
  • Assessment of AKT activation and autophagy levels.
  • Evaluation of kidney cell apoptosis following cadmium exposure.

Main Results:

  • Both mTORC1 and mTORC2 were found to mediate an antiapoptotic mechanism in renal cells by regulating AKT activity.
  • Inhibition of mTORC1 or mTORC2 significantly exacerbated cadmium-induced kidney cell apoptosis.
  • AKT activation was identified as a key mediator in mTORC1/mTORC2-driven antiapoptosis.
  • mTOR activators were observed to inhibit excessive autophagy, alleviate apoptosis, and promote cell survival.

Conclusions:

  • mTORC1 and mTORC2 play critical antiapoptotic roles in cadmium-exposed kidney cells.
  • The mTOR-AKT signaling pathway is essential for protecting renal cells against cadmium toxicity.
  • Modulating mTOR activity presents a promising therapeutic strategy for mitigating cadmium-induced kidney injury and related renal diseases.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K